HOME >> MEDICINE >> NEWS
Research provides promising evidence of new drug therapies in lethal lung disease

Several promising new treatments may prolong lives as well as improve the quality of life for people living with pulmonary arterial hypertension. Research showing benefits of these novel drug therapies for lethal lung disease will be discussed today at the 26th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT).

Pulmonary arterial hypertension (PAH), high blood pressure in the pulmonary arteries in the lungs, is a life-threatening disease. Therapeutic options have, until recently, been limited and many patients with PAH faced lung transplantation. In recent years, research has identified a number of novel drug therapies that have shown to improve both quality and quantity of life in patients with this very serious illness.

During the ISHLT Meeting, researchers will discuss the results of new trial evidence of drugs including the endothelin antagonists Sitaxentan and Bosentan, prostenoids including Trepostenil and Prostacyclin, and Viagra (sildenafil citrate), marketed as RevatioTM for PAH, used as single agents and in combination.

PAH is caused when the smaller blood vessels in the lungs become more resistant to blood flow forcing the right ventricle of the heart to work harder to pump enough blood through the lungs. For example, Revatio (Viagra) helps patients by causing the pulmonary arteries to dilate which lessens the lungs resistance to blood flow and reduces the workload of the heart.

"It is an extremely exciting time for physicians involved in the care of patients with pulmonary arterial hypertension because of the explosion of novel drugs within the last few years," commented Paul A. Corris, Professor of Thoracic Medicine at the University of Newcastle upon Tyne, UK and Director, North of England Pulmonary Vascular Service. "Although these drugs cannot yet be considered a cure for pulmonary arterial hypertension, results of medical therapy are ext
'"/>

Contact: Melissa Aguillon
maguillon@masonpr.com
210-745-2611
International Society for Heart and Lung Transplantation
7-Apr-2006


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
5. Wesley Research Institute study targets pharmacists to help diabetes sufferers
6. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
7. Research probes seniors plans for end-of-life care
8. DFG approves 11 new Collaborative Research Centers
9. Research shows survival benefit for leukemia patients treated with arsenic trioxide
10. Researchers call for investigation into links between khat use and psychiatric disorders
11. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... ... 2018 , ... Becker's Healthcare named the following institutions to ... programs." , The hospitals named on this list are national leaders in cardiovascular ... pioneered groundbreaking procedures and remain on the forefront of heart care today. Others ...
(Date:12/10/2018)... ... December 10, 2018 , ... The most active U.S. markets ... once again host the CWCBExpo (Cannabis World Congress) leading B2B trade shows and conferences. ... York, May 29-June 1, 2019, Jacob K. Javits Convention Center, New York, NY , ...
(Date:12/8/2018)... , ... December 07, 2018 , ... ... Community Service for its annual tradition of supporting non-profit organizations through fun, creative ... Garland employees helping raise more than $400,000 for charities in northeast Ohio and ...
(Date:12/8/2018)... ... 08, 2018 , ... The Human Animal Bond Research Institute ... parents, has become an official supporter of HABRI and its research on the ... of human-animal bond research, whiskerDocs is demonstrating its commitment to the human-animal bond ...
(Date:12/6/2018)... ... December 06, 2018 , ... We all know stress is ... solutions. M.D.-formulated Relaxium Calm is a dietary supplement developed to promote relaxation and ... extract of the ashwagandha root. Ashwagandha is a powerful herb that has been ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... , ... November 29, 2018 , ... More than 205,000 ... on the largest diabetes organizations to significantly increase funding for type 1 diabetes cure ... remained mostly flat since then. , An estimated two million Americans are affected by ...
(Date:11/28/2018)... ... November 28, 2018 , ... Satin Fine Foods, a manufacturer of cake ... Hudson Valley Honor Flight on Sept 28th, 2018 at the HVNY office in Walden ... to HVHF by Kevin O’Reilly, Founder and CEO of Satin Fine Foods, Inc. , ...
(Date:11/28/2018)... , ... November 28, 2018 , ... ... Corporation has been published and is available to view on the company’s ... crystal X-ray diffraction, published by Rigaku Oxford Diffraction , serving the X-ray ...
Breaking Medicine Technology:
Cached News: